Related references
Note: Only part of the references are listed.Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnover
Rosy Reynolds et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes
Rosy Reynolds et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
The zeitgeist of resistance
David Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory
Neil Woodford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
CTX-M: changing the face of ESBLs in Europe
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases
Matthew J. Ellington et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Comparative review of the carbapenems
George G. Zhanel et al.
DRUGS (2007)
Tigecycline: in-vitro performance as a predictor of clinical efficacy
P. Hawkey et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom
E. Karisik et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel
Shiri Navon-Venezia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum beta-lactamases
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase
E Elliott et al.
CLINICAL INFECTIOUS DISEASES (2006)
Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent Oxyrase to standardize the test method
PA Bradford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
G Muralidharan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Outbreak of Klebsiella pneumoniae producing a new carbapenern hydrolyzing class a β-lactamase, KPC-3, in a New York Medical Center
N Woodford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains
I Stock et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999
DM Livermore et al.
EMERGING INFECTIOUS DISEASES (2002)
Detection of β-lactamase-mediated resistance
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients
A Marron et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis
MH Reacher et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)